Drug Information

Drug General Information
Drug ID
D07SWU
Former ID
DCL000250
Drug Name
TM30338
Indication Obesity [ICD9: 278; ICD10:E66] Discontinued in Phase 2 [548209]
Company
7TMPharma.
Target and Pathway
Target(s) Neuropeptide Y receptor type 2 Target Info Modulator
Neuropeptide Y receptor type 4 Target Info Modulator
KEGG Pathway Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
GPCR downstream signaling
References
Ref 548209Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023122)